Recombinant full length protein (Human).
Our Abpromise guarantee covers the use of ab16857 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ELISA||Use at an assay dependent concentration.|
|IP||Use a concentration of 2 µg/ml.|
ab16857 has not yet been referenced specifically in any publications.